Statement by Ralph G. Neas, President and CEO, Generic Pharmaceutical Association, Regarding the National Community Pharmacists Association's 2013 NCPA Digest

Published Online: Wednesday, October 16, 2013
Follow Pharmacy_Times:
PRES RELEASE

WASHINGTON, DC (October 16, 2013) — The Generic Pharmaceutical Association (GPhA) applauds new findings from the National Community Pharmacists Association’s (NCPA) 2013 NCPA Digest, particularly the positive role that medication adherence and generic pharmaceuticals play in reducing health costs for millions of people.

Independent community pharmacists are critical to our health system, tackling the challenges of medication adherence head-on to ensure that more affordable generic medicines reach patients. One reason why adherence continues to be a challenge for many patients is the high cost of brand name therapies. That is why it is important, especially among the Medicare low-income subsidy population, to ensure access to generic medicines.

It is also commendable that community pharmacists report dispensing generics 77% of the time, an increase from years past and a record high, according to the report. Generic medicines remain one of the few proven, reliable ways to reduce health costs, generating savings of one trillion dollars over the past decade. Independent community pharmacies, which the report states now number 23,029 across America, are valued partners in the generic pharmaceutical industry’s ongoing efforts to lower health costs and provide more affordable treatment options especially in rural and underserved regions.

For more information on the 2013 NCPA Digest, visit: https://www.ncpanet.org/index.php/news-releases/1825-ncpa-digest-community-pharmacists-promoting-medication-adherence-generic-drugs-to-improve-health-outcomes-and-reduce-costs.
Related Articles
The National Community Pharmacists Association issued the following statement today from President John T. Sherrer, RPh in response to the 2014 Gallup survey “U.S. Views on Honesty and Ethical Standards in Professions”:
The Generic Pharmaceutical Association welcomes the FDA’s proposed rule to amend its prescription drug and biological product labeling regulations to require electronic distribution of the prescribing information intended for healthcare professionals.
The Generic Pharmaceutical Association has serious concerns about the unbalanced structure of the Trans-Pacific Partnership agreement in its current form.
The National Community Pharmacists Association issued the following statement today from CEO B. Douglas Hoey, RPh, MBA in response to a study by the Centers for Medicare & Medicaid Services of beneficiary access to discounted copays at “preferred” pharmacies in Medicare drug plans.
Latest Issues
$auto_registration$